Author
Listed:
- Yogesh Krishnarao Gurav
- Bhavani Shankara Bagepally
- Natthakan Chitpim
- Abhasnee Sobhonslidsuk
- Mohan Digambar Gupte
- Usa Chaikledkaew
- Ammarin Thakkinstian
- Montarat Thavorncharoensap
Abstract
Several hepatitis A outbreaks have recently been reported in Kerala state, India. To inform coverage decision of hepatitis A vaccine in Kerala, this study aimed to examine the cost-effectiveness of 1) hepatitis A vaccination among children aged 1 year and individuals aged 15 years, and 2) serological screening of individuals aged 15 years and vaccination of susceptible as compared to no vaccination or vaccination without serological screening. Both live attenuated hepatitis A vaccine and inactivated hepatitis A vaccine were considered in the analysis. A combination of decision tree and Markov models with a cycle length of one year was employed to estimate costs and benefits of different vaccination strategies. Analysis were based on both societal and payer perspectives. The lifetime costs and outcomes were discounted by 3%. Our findings indicated that all strategies were cost-saving for both societal and payer perspectives. Moreover, budget impact analysis revealed that vaccination without screening among individuals aged 15 years could save the government’s budget by reducing treatment cost of hepatitis A. Our cost-effectiveness evidence supports the inclusion of hepatitis A vaccination into the vaccination program for children aged 1 year and individuals aged 15 years in Kerala state, India.
Suggested Citation
Yogesh Krishnarao Gurav & Bhavani Shankara Bagepally & Natthakan Chitpim & Abhasnee Sobhonslidsuk & Mohan Digambar Gupte & Usa Chaikledkaew & Ammarin Thakkinstian & Montarat Thavorncharoensap, 2024.
"Cost-effective analysis of hepatitis A vaccination in Kerala state, India,"
PLOS ONE, Public Library of Science, vol. 19(6), pages 1-17, June.
Handle:
RePEc:plo:pone00:0306293
DOI: 10.1371/journal.pone.0306293
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0306293. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.